Validating the effects of the two de novo mutations in DYSF on dysferlin protein expression, localization, structure, and function in vivo and in vitro was important to reveal the pathogenic mechanism of dysferlinopathy. This evidence concerns the gene DYSF and neuromuscular disease caused by qualitative or quantitative defects of dysferlin.